Related Experiment Video
Updated: Aug 10, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device
Vijay Kumar1, Trista Madsen, Haihong Zhu
1Thermogenesis Corp., Rancho Cordova, California, USA. vkumar@thermogenesis.com
Autologous thrombin production using a device (TPD) shows temperature affects stability. Optimal conditions yield active thrombin with up to 6-hour stability for surgical use.
Area of Science:
- Biochemistry
- Biotechnology
- Surgical Hemostasis
Background:
- Autologous thrombin, derived from patient plasma, is valuable for surgical hemostasis.
- Traditional methods of thrombin generation result in rapid degradation, limiting clinical utility.
- The Thrombin Processing Device (TPD) was developed to improve the stability and practicality of autologous thrombin production.
Purpose of the Study:
- To evaluate the stability of autologous thrombin generated by the Thrombin Processing Device (TPD).
- To determine the optimal production and storage temperatures for maximizing thrombin activity and shelf-life.
- To assess the feasibility of using TPD-generated thrombin for intraoperative hemostasis.
Main Methods:
- Autologous thrombin was produced using the TPD by activating plasma with calcium chloride and ethanol.
- Thrombin was generated at three different temperatures: 18°C, 24°C, and 27°C.
- The produced thrombin was stored at its production temperature, 4°C, or 35°C for up to 6 hours.
- Thrombin activity was quantified by measuring the time to clot formation using fibrinogen concentrate.
Main Results:
- Thrombin produced at 18°C showed limited stability, degrading significantly within 4 hours, especially when stored at 35°C.
- Thrombin produced at 24°C and 27°C demonstrated remarkable stability, maintaining rapid clotting times for up to 6 hours at both 4°C and 35°C storage temperatures.
- Optimal stability was achieved when thrombin was produced at 24°C or 27°C and subsequently stored at 4°C.
Conclusions:
- The stability of autologous thrombin generated by the TPD is significantly influenced by both production and storage temperatures.
- The TPD can reliably produce active autologous human thrombin with a clinically relevant stability of up to 6 hours.
- Specific production (24°C or 27°C) and storage (4°C) parameters are recommended for maximizing the efficacy of TPD-generated thrombin in surgical settings.
More Related Videos
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
06:16Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
Published on: April 19, 2024